Semaglutide, a glucagon-like peptide-1 receptor agonist, is linked with significant cardiorenal improvements and a favorable safety profile in adults with
Findings…
Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes
Semaglutide, a glucagon-like peptide-1 receptor agonist, is linked with significant cardiorenal improvements and a favorable safety profile in adults with
Findings…